Answers are grounded in this paper and cite their sources.
Synthesis of thiazolo[5,4-f]quinoline derivatives shows potent antimicrobial activity against Staphylococcus aureus and Escherichia coli, suggesting novel drug development potential.
In pursuit of novel antimicrobial agents, a series of thiazolo[5,4-f]quinoline derivatives incorporating pyridine and thiophene moieties were synthesized and structurally characterized using IR and 1 H-NMR spectroscopy. The synthetic strategy employed diverse condensation and cyclization reactions involving cyanoacetamide intermediates, aryl isothiocyanates, and α-halocarbonyl compounds. The resulting compounds were evaluated for their antimicrobial efficacy against Staphylococcus aureus , Escherichia coli , and Candida albicans . Notably, compounds 18 , 19 , and 23 exhibited potent broad-spectrum activity, surpassing standard drugs such as chloramphenicol and cephalothin in several assays (MIC = 3.125–6.25 µg/mL). Structure-activity relationship (SAR) analysis revealed that the incorporation of bulky, lipophilic aromatic systems and electron-withdrawing substituents significantly enhanced antimicrobial potency. Molecular docking studies further supported these findings, with compound 19 demonstrating the strongest binding affinity (-6.6951 kcal/mol) to bacterial DNA gyrase (PDB: 6F86) via a synergistic network of hydrogen bonds and π-interactions. These results highlight the thiazoloquinoline framework, particularly derivatives bearing thiophene and naphthoyl functionalities, as a promising scaffold for future antimicrobial drug development.
No takes yet. Share an insight, caveat, or question.
Soliman et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: